Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2024-2031

Ophthalmology Devices Market size was valued at USD 28.33 Billion in 2022 and is poised to grow from USD 29.52 Billion in 2023 to USD 36.26 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).

The competitive environment of the Ophthalmology Devices Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Detailed information includes jurisdiction over company design, company finances, earnings, market potential, investment in research and development, market innovation, presence, manufacturing locations and manufacturing facilities, production capacity, company strengths and weaknesses, product launches, product expansion and expansion, and applications. The above data points provided only relate to the perspective of companies in the market. Key companies operating in this market include Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation. 'Novartis AG', 'Carl Zeiss Meditec AG', 'Essilor International S.A.', 'HAAG-Streit Holding AG', 'Johnson & Johnson', 'Nidek Co., Ltd.', 'Topcon Corporation', 'Valeant Pharmaceuticals International, Inc.', 'Ziemer Ophthalmic Systems AG', 'Hoya Corporation', 'Alcon Vision LLC', 'Bausch & Lomb Incorporated', 'Alcon', 'Regeneron Pharmaceuticals Inc.', 'Bausch & Lomb Incorporated', 'HOYA Corporation', 'The Cooper Companies Inc.', 'Santen Pharmaceutical Co., Ltd.'

Eye infections are a major cause of severe eye pain. Eye pain is accompanied by symptoms such as dry eyes, burning and pain. This can be caused by many factors including foreign irritants, infection or trauma. Eyelashes or dirt particles, smoke, dust or some harsh makeup products are the most common causes of irritated, red and watery eyes. With increasing pharmaceutical industry and pollution worldwide, the prevalence of eye pain continues to show an increase. Chemical burns and flash burns cause severe eye pain and severity due to irritation of the cornea. Style and blepharitis are common causes of eye pain as they increase the sensitivity of the eye and oil glands surrounding the area.

The introduction of new equipment, accessories, contact lenses, etc. has increased the demand for these devices for healthcare professionals and patients. For example, micro-invasive glaucoma (MIGs) cosmetic surgery in new has been one of the fastest growing technologies for the treatment of mild to moderate glaucoma. Market players are focusing on the innovative micro-invasive cataract surgical implants that will drive the growth of the ophthalmic devices market during the forecast period.

North America controlled 43% of the market by 2022. The major factors influencing the market were the continuous expansion of the aging population and chronic eye problems due to high stress and lifestyle. The negative course of diabetic retinopathy is common. The ophthalmic device market in this region is expected to be driven by additional reimbursements for ophthalmology treatments and stringent regulations designed to ensure patient safety. North America, especially the United States, holds a dominant position in the market. The industry benefits from well-established healthcare infrastructure, higher healthcare costs and a higher patient population with various eye diseases.